Cubist Pharmaceuticals to Present at May 2008 Investor Conferences
12:09p ET April 28, 2008 (Business Wire)
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that David McGirr, SVP and CFO, will present on Wednesday, May 14th at 10:40 A.M. CDT, at the RW Baird 2008 Growth Stock Conference being held at the Four Seasons Hotel in Chicago, IL. Mr. McGirr will also present on Wednesday, May 21st at 11:00 A.M. EDT, at the Citigroup Healthcare Conference taking place at the Hilton Hotel, New York, NY. These presentations will include discussion of the company's business activities, financial outlook, and current news.
Live webcasts of the presentations (Citigroup will be audio only) will be accessible through Cubist's website at www.cubist.com in the Investor Relations Conference Calendar section. The webcasts will be available on Cubist's website for a period of 14 days after the presentations.
About Cubist
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. In the U.S., Cubist markets CUBICIN(R) (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides. The Cubist product pipeline includes DX-88, a recombinant human protein in Phase II clinical trials for the prevention of blood loss during cardiothoracic surgery, and pre-clinical programs that address unmet medical needs in Gram-positive infections, Gram-negative infections, CDAD (Clostridium difficile-associated diarrhea), and HCV (Hepatitis C infections). Cubist is headquartered in Lexington, MA. Additional information can be found at Cubist's web site at www.cubist.com.
Cubist and CUBICIN are registered trademarks of Cubist Pharmaceuticals, Inc.
SOURCE: Cubist Pharmaceuticals, Inc.
Send stock manipulators to: enforcement@sec.gov-and to jail.
